Skip to navigation Skip to content

COVID-19

Share

In this article

COViMS

COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society and the Consortium of MS Centers to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.  
 
If you have a patient who has highly suspicious or laboratory confirmed COVID19, we ask that you enter those cases into the database.  As the purpose is outcomes of COVID19, Please report only after a minimum of 7 days and sufficient time has passed to observe the disease course through resolution of acute illness or death. View current data.

Enter a case

Enter a case

Overview

We are closely watching the COVID-19 situation and taking action as we all move through this uncharted territory. We know that the best information for someone living with MS about their unique situation comes from their healthcare providers, and we refer them to you first whenever possible. But we also know that due to the unique circumstances around COVID-19, that may be more difficult.

We are here to partner with you to provide your patients with a trustworthy platform of fact-based information about COVID19 and multiple sclerosis, including information on the COVID-19 vaccine. The MS Navigator® program is an excellent resource for MS-specific support and information nationwide.

MS and COVID-19: A Webinar Series for Healthcare Providers

Join your colleagues for a live webinar series addressing the latest news in MS and COVID-19. Please check back for updates on the next COVID-19 webinar.

COVID-19 Vaccines

Clinical Practice Resources

Resources for Patients

Telehealth

Share

© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.